Emerging RNA editing biomarkers will foster drug development.

van der Laan, Siem; Salvetat, Nicolas; Weissmann, Dinah; Molina, Franck

van der Laan, Siem; Salvetat, Nicolas; Weissmann, Dinah; Molina, Franck.

Afiliação

van der Laan S; Sys2Diag FRE3690 CNRS/ALCEDIAG, Complex System Modeling and Engineering for Diagnosis, Cap delta/Parc Euromédecine, 1682 rue de la Valsière CS 61003, 34184 Montpellier Cedex 4, France. Electronic address: siem.van-der-laan@sys2diag.cnrs.fr.
Salvetat N; Sys2Diag FRE3690 CNRS/ALCEDIAG, Complex System Modeling and Engineering for Diagnosis, Cap delta/Parc Euromédecine, 1682 rue de la Valsière CS 61003, 34184 Montpellier Cedex 4, France.
Weissmann D; Sys2Diag FRE3690 CNRS/ALCEDIAG, Complex System Modeling and Engineering for Diagnosis, Cap delta/Parc Euromédecine, 1682 rue de la Valsière CS 61003, 34184 Montpellier Cedex 4, France.
Molina F; Sys2Diag FRE3690 CNRS/ALCEDIAG, Complex System Modeling and Engineering for Diagnosis, Cap delta/Parc Euromédecine, 1682 rue de la Valsière CS 61003, 34184 Montpellier Cedex 4, France. Electronic address: franck.molina@sys2diag.cnrs.fr.

Drug Discov Today ; 22(7): 1056-1063, 2017 07.

Article em En | MEDLINE | ID: mdl-28188894

Assuntos

Descoberta de Drogas; Edição de RNA; Animais; Biomarcadores; Humanos; Ideação Suicida

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Edição de RNA / Descoberta de Drogas Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google